Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: Expert consensus statement

HPB

Volumn 15, Issue 2, 2013, Pages 131-133

  Martin, Robert C G ^a   Salem, Riad ^b   Adam, Rene ^c   Dixon, Elijah ^d  

^a University of Louisville School of Medicine   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c HÔPITAL PAUL BROUSSE   (France)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER SURVIVAL; CHEMOEMBOLIZATION; COLORECTAL LIVER METASTASIS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LENGTH OF STAY; LIVER METASTASIS; LIVER RESECTION; MICROWAVE THERAPY; NOTE; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL;

EID: 84872201926     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00565.x     Document Type: Note

References (19)

1. Abdalla EK, Bauer TW, Chun YS, D'Angelica M, Kooby DA, Jarnagin WR,. (2013) Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statement. HPB 15: 119-130.
2. Vauthey JN, Choti MA, Helton WS,. (2006) AHPBA/SSO/SSAT Consensus Conference on hepatic colorectal metastases: rationale and overview of the conference. January 25, 2006. Ann Surg Oncol 13: 1259-1260. (Pubitemid 44435790)
3. Govaert KM, van Kessel CS, Lolkema M, Ruers TJ, Borel Rinkes IH,. (2012) Does radiofrequency ablation add to chemotherapy for unresectable liver metastases? Curr Colorectal Cancer Reports 8: 130-137.
4. Ruers T, Punt C, van, Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, et al. (2012) Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: A randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. doi: 10.1093/annonc/mds053. Epub 2012 Mar 19.
5. Hammill CW, Billingsley KG, Cassera MA, Wolf RF, Ujiki MB, Hansen PD,. (2011) Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol 18: 1947-1954.
6. Khajanchee YS, Hammill CW, Cassera MA, Wolf RF, Hansen PD,. (2011) Hepatic resection vs. minimally invasive radiofrequency ablation for the treatment of colorectal liver metastases: A Markov analysis. Arch Surg 146: 1416-1423.
7. Whitney R, Tatum C, Hahl M, Ellis S, Scoggins CR, McMasters K, et al. (2009) Safety of hepatic resection in metastatic disease to the liver after yttrium-90 therapy. J Surg Res 166: 236-240.
8. Bower M, Metzger T, Robbins K, Tomalty D, Valek V, Boudny J, et al. (2010) Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: A multi-institutional study. HPB 12: 31-36.
9. Brown RE, Bower MR, Metzger TL, Scoggins CR, McMasters KM, Hahl MJ, et al. (2011) Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? HPB 13: 91-95.
10. Polignano FM, Quyn AJ, de, Figueiredo RS, Henderson NA, Kulli C, Tait IS,. (2008) Laparoscopic versus open liver segmentectomy: prospective, case-matched, intention-to-treat analysis of clinical outcomes and cost-effectiveness. Surg Endosc 22: 2564-2570.
11. Polignano FM, Quyn AJ, Sanjay P, Henderson NA, Tait IS,. (2012) Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis. Surg Endosc 26: 2571-2578.
12. Huh JW, Koh YS, Kim HR, Cho CK, Kim YJ,. (2011) Comparison of laparoscopic and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases. Surg Endosc 25: 193-198.
13. Kim SH, Lim SB, Ha YH, Han SS, Park SJ, Choi HS, et al. (2008) Laparoscopic-assisted combined colon and liver resection for primary colorectal cancer with synchronous liver metastases: initial experience. World J Surg 32: 2701-2706.
14. Martin RC, Scoggins CR, McMasters KM,. (2010) Laparoscopic hepatic lobectomy: Advantages of a minimally invasive approach. J Am Coll Surg 210: 627-636.
15. Martin RC, Edwards MJ, McMasters KM,. (2004) Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 188: 714-721.
16. Onaitis M, Morse M, Hurwitz H, Cotton P, Tyler D, Clavien P, et al. (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237: 782-788.
17. Mocellin S, Pilati P, Lise M, Nitti D,. (2007) Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol 25: 5649-5654.
18. Martin RC, Howard J, Tomalty D, Robbins K, Padr R, Bosnjakovic PM, et al. (2010) Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Intervent Radiol 33: 960-966.
19. Martin RC, 2nd, Scoggins CR, Tomalty D, Schreeder M, Metzger T, Tatum C, et al. (2012) Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial. J Gastrointest Surg 16: 1531-1538.